Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232218 | SCV001404766 | likely benign | Atrioventricular septal defect 4 | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004033158 | SCV003534669 | uncertain significance | Cardiovascular phenotype | 2021-11-22 | criteria provided, single submitter | clinical testing | The c.1085G>A (p.R362H) alteration is located in exon 6 (coding exon 5) of the GATA4 gene. This alteration results from a G to A substitution at nucleotide position 1085, causing the arginine (R) at amino acid position 362 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV003442793 | SCV004168306 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |